Medicare Enrolled
Dr. Peter Nicholas, M.D.
Optician · Wyomissing, PA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nicholas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nicholas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nicholas
Dr. Peter Nicholas is an optician specialist in Wyomissing, PA, with 21 years of NPI registration. Based on federal Medicare data, Dr. Nicholas performed 93,292 Medicare services across 2,339 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nicholas received a total of $6,460 from 24 pharmaceutical and/or device companies across 384 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nicholas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years in practice
▲ Top 0% volume in PA
$6,460 industry payments
Medicare Practice Summary
Medicare Utilization ↗93,292
Medicare services
Top 0% in PA for optician
2,339
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~4,442 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 30,506 | $5 | $8 |
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
24,000 | $4 | $14 |
| Denosumab injection (Prolia/Xgeva) | 16,800 | $18 | $30 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
7,550 | $11 | $42 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
5,800 | $34 | $83 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,530 | $26 | $100 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
1,970 | $1 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
607 | $85 | $140 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
484 | $66 | $110 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
324 | $10 | $50 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
256 | $54 | $210 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
251 | $1 | $15 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
184 | $88 | $290 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
142 | $41 | $120 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
113 | $21 | $80 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
77 | $47 | $135 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
67 | $8 | $10 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
58 | $36 | $159 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
58 | $35 | $198 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
53 | $46 | $174 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
41 | $25 | $70 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
38 | $23 | $60 |
| Methylprednisolone acetate injection, 20 mg A 20 mg injection of methylprednisolone acetate, a corticosteroid medication. This code specifies the drug and dosage administered. |
37 | $5 | $10 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
32 | $26 | $60 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
32 | $12 | $45 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
32 | $43 | $70 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
25 | $10 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 25 | $6 | $10 |
| Pelvis X-ray, 1-2 views An X-ray imaging test of the pelvic area using one to two different angles to visualize the bones and joints. |
24 | $21 | $50 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
24 | $20 | $60 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
21 | $30 | $70 |
| Tendon or ligament injection A procedure involving the injection of medication into a tendon or ligament. |
20 | $37 | $187 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
20 | $96 | $200 |
| X-ray of lower and sacral spine, minimum of 4 views An X-ray imaging test of the lower back and sacrum using at least four different angles to visualize the bones and joints. |
18 | $31 | $100 |
| Total calcium level test A blood test that measures the total amount of calcium in your body. |
16 | $5 | $18 |
| New patient office visit, complex (60-74 min) | 16 | $137 | $250 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
15 | $13 | $55 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
14 | $12 | $44 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
12 | $5 | $44 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
18.6% high complexity
79.7% medium
1.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,460
Total received (2018-2024)
Avg $923/year across 7 years
Top 22% in PA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
24
Companies
384
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,460 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,049
2023
$887
2022
$321
2021
$165
2020
$228
2019
$1,679
2018
$2,130
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
UCB, Inc.
$258
AstraZeneca Pharmaceuticals LP
$213
GlaxoSmithKline, LLC.
$114
ABBVIE INC.
$86
Janssen Biotech, Inc.
$83
Amgen Inc.
$63
Genentech USA, Inc.
$53
Novartis Pharmaceuticals Corporation
$46
Lilly USA, LLC
$40
E.R. Squibb & Sons, L.L.C.
$37
Alexion Pharmaceuticals, Inc.
$35
GENZYME CORPORATION
$22
Top 3 companies account for 55.8% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$777
UCB, Inc.
$645
Janssen Biotech, Inc.
$642
Novartis Pharmaceuticals Corporation
$624
E.R. Squibb & Sons, L.L.C.
$591
PFIZER INC.
$533
AbbVie, Inc.
$509
Amgen Inc.
$481
AstraZeneca Pharmaceuticals LP
$439
ABBVIE INC.
$293
GlaxoSmithKline, LLC.
$261
Horizon Therapeutics plc
$100
GENZYME CORPORATION
$87
Lilly USA, LLC
$81
Actelion Pharmaceuticals US, Inc.
$57
MEDEXUS PHARMA, INC.
$55
MEDAC PHARMA, INC.
$49
Alexion Pharmaceuticals, Inc.
$48
Ferring Pharmaceuticals Inc.
$41
Takeda Pharmaceuticals U.S.A., Inc.
$40
AbbVie Inc.
$39
Celgene Corporation
$30
Supernus Pharmaceuticals, Inc.
$20
Radius Health, Inc.
$19
Top 3 companies account for 31.9% of all-time payments
Associated products mentioned in payments ›
Actemra · Amitiza · BENLYSTA · Bimzelx · COSENTYX · Cimzia · ELIQUIS · EUFLEXXA · EVENITY · Enbrel · FORTEO · Humira · KEVZARA · KRYSTEXXA · LYRICA · OPSUMIT · OPSUMIT MACITENTAN · ORENCIA · Otezla · PREVNAR - 13 · Prolia · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · Skyrizi · Strensiq · TALTZ · TAVNEOS · TREMFYA · TROKENDI XR · Tavneos · Tymlos · Uloric · VENTAVIS ILOPROST · XELJANZ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
76
Per 100K population
17.7
County median income
$77,684
Nearest hospital
SURGICAL INSTITUTE OF READING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nicholas is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with low-engagement industry engagement, with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nicholas experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Nicholas performed 30,506 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nicholas receive payments from pharmaceutical companies?
Yes. Dr. Nicholas received a total of $6,460 from 24 companies across 384 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nicholas's costs compare to other opticians in Wyomissing?
Dr. Nicholas's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nicholas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Wyomissing
Browse opticians in Wyomissing ranked by procedure volume and transparency data.
Highest volume
Top Opticians in PA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in PA
Which PA opticians receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
UCB, Inc. Payments to Doctors
See all physicians who received payments from UCB, Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology